Coreg and Septra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coreg (carvedilol) and Septra (sulfamethoxazole; trimethoprim). Common drug interactions include contusion among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Coreg and Septra. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.



On Aug, 09, 2026

86 people who take Coreg and Septra together, and have interactions are studied.

Coreg and Septra drug interactions.

What are the common drug interactions of Coreg and Septra, by gender? *:

female:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Anaemia (lack of blood)
  3. Dyspnoea (difficult or laboured respiration)
  4. Abdominal pain
  5. Fall
  6. Cellulitis (infection under the skin)
  7. Dehydration (dryness resulting from the removal of water)
  8. Fatigue (feeling of tiredness)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Blood urea increased

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Nausea (feeling of having an urge to vomit)
  3. Diarrhoea
  4. Weight decreased
  5. Abdominal pain upper
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Death
  9. Dizziness
  10. International normalised ratio increased

What are the common drug interactions of Coreg and Septra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Graft dysfunction
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Transplant rejection (a transplant material is not worked)
  4. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  5. Diarrhoea

20-29:

  1. Drug hypersensitivity
  2. Pneumonia
  3. Pulmonary toxicity (side effects on the lungs)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Hypotension (abnormally low blood pressure)
  7. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  8. Pulmonary oedema (fluid accumulation in the lungs)

30-39:

  1. Abdominal pain upper
  2. Alcohol use
  3. Arrhythmia (irregular heartbeat)
  4. Blood thyroid stimulating hormone increased
  5. Cardiac failure congestive
  6. Cardiomegaly (increased size of heart than normal)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Cytomegalovirus test positive
  9. Electrocardiogram qt corrected interval prolonged
  10. Electrocardiogram qt prolonged

40-49:

  1. Injury
  2. Kidney transplant rejection
  3. Pain
  4. Arthralgia (joint pain)
  5. Complications of transplanted kidney
  6. Dyspnoea (difficult or laboured respiration)
  7. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
  8. Hypotension (abnormally low blood pressure)
  9. Muscular weakness (muscle weakness)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

50-59:

  1. Diarrhoea
  2. Renal failure (kidney dysfunction)
  3. Loss of consciousness
  4. Myocarditis (inflammation of heart muscle myocardium)
  5. Pulse absent
  6. Abdominal distension
  7. Abdominal pain upper
  8. Abscess (pus)
  9. Anaemia (lack of blood)
  10. Arthralgia (joint pain)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Fall
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Decreased appetite
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Renal failure (kidney dysfunction)
  9. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  10. Weight decreased

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 7 people, 8.14%
  2. Cardiac Disorder: 7 people, 8.14%
  3. Multiple Myeloma (cancer of the plasma cells): 6 people, 6.98%
  4. Transplant Rejection (a transplant material is not worked): 5 people, 5.81%
  5. Swelling: 5 people, 5.81%
  6. Pain: 5 people, 5.81%
  7. Infection: 5 people, 5.81%
  8. Gout (uric acid crystals building up in the body): 5 people, 5.81%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 5.81%
  10. Dyspnea (difficult or laboured breathing): 5 people, 5.81%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and Septra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coreg and Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coreg:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coreg and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Septra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carvedilol and sulfamethoxazole; trimethoprim (the active ingredients of Coreg and Septra, respectively), and Coreg and Septra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: